Modulating mGluR5 and 5-HT1A/1B receptors to treat l-DOPA-induced dyskinesia: Effects of combined treatment and possible mechanisms of action
Keywords: l-DOPA-induced dyskinesia; Parkinson's disease; Metabotropic glutamate receptor 5; DA agonist; 6-OHDA rat model; 5-HT1A/1B agonists;